Dr. Perminder J Bhatia
Claim this profileNeuro-Pain Medical Center
Studies Alzheimer's Disease
Studies Parkinson's Disease
16 reported clinical trials
17 drugs studied
Area of expertise
1Alzheimer's Disease
ApoE positive
ApoE negative
2Parkinson's Disease
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Perminder J Bhatia is currently running
Cenobamate
for Focal Seizures
Cenobamate (YKP3089) is a small molecule approved in the United States (US), Europe and several other countries around the world for the treatment of Partial-Onset (focal) seizures in adult subjects (≥18 years of age). In the US it is approved for use as monotherapy, however, there is little clinical data assessing its use as monotherapy in adults with POS. This study is designed to explore the effectiveness of doses of 100 mg/day and 200 mg/day as monotherapy in adult subjects with newly diagnosed or recurrent POS/focal onset epilepsy.
Recruiting3 awards Phase 41 criteria
Mevidalen
for Alzheimer's Disease
The main purpose of this study is to look at how safe the study drug (mevidalen) is and whether it works to alleviate symptoms when given to people with mild to moderate Alzheimer Disease (AD) dementia. This is done by looking at participants: thinking and memory (cognition), everyday activities and sleep, AD symptoms, physical activity, irritability or anxiety. The study is expected to last approximately 26 weeks and may include up to 14 visits.
Recruiting0 awards Phase 21 criteria
More about Perminder J Bhatia
Clinical Trial Related1 year of experience running clinical trials · Led 16 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Perminder J Bhatia has experience with
- Placebo
- Tavapadon
- Remternetug (IV)
- Remternetug (SC)
- Simufilam
- Dipraglurant
Breakdown of trials Perminder J Bhatia has run
Alzheimer's Disease
Parkinson's Disease
Psychomotor Agitation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Perminder J Bhatia specialize in?
Perminder J Bhatia focuses on Alzheimer's Disease and Parkinson's Disease. In particular, much of their work with Alzheimer's Disease has involved ApoE positive patients, or patients who are ApoE negative.
Is Perminder J Bhatia currently recruiting for clinical trials?
Yes, Perminder J Bhatia is currently recruiting for 6 clinical trials in Fresno California. If you're interested in participating, you should apply.
Are there any treatments that Perminder J Bhatia has studied deeply?
Yes, Perminder J Bhatia has studied treatments such as Placebo, Tavapadon, Remternetug (IV).
What is the best way to schedule an appointment with Perminder J Bhatia?
Apply for one of the trials that Perminder J Bhatia is conducting.
What is the office address of Perminder J Bhatia?
The office of Perminder J Bhatia is located at: Neuro-Pain Medical Center, Fresno, California 93710 United States. This is the address for their practice at the Neuro-Pain Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.